Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JNJ0966 是高选择性 MMP-9酶原抑制剂,其 IC50=440 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 497 | 现货 | ||
2 mg | ¥ 729 | 现货 | ||
5 mg | ¥ 1,230 | 现货 | ||
10 mg | ¥ 1,990 | 现货 | ||
25 mg | ¥ 3,370 | 现货 | ||
50 mg | ¥ 4,890 | 现货 | ||
100 mg | ¥ 6,860 | 现货 | ||
500 mg | ¥ 13,800 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 987 | 现货 |
产品描述 | JNJ0966 is a highly selective MMP-9 zymogen inhibitor (IC50: 440 nM). |
靶点活性 | MMP9 zymogen:440 nM |
体外活性 | The activations of proMMP-1, proMMP-2, and proMMP-3 are not significantly different in the presence or absence of 10 μM JNJ0966, whereas proMMP-9 activation by trypsin is significantly attenuated by JNJ0966. The addition of JNJ0966 to the reaction results in a significant reduction in fully processed MMP-9 and an apparent accumulation of the intermediate species[1]. |
体内活性 | JNJ0966 was efficacious in reducing disease severity in a mouse experimental autoimmune encephalomyelitis model. The exposures of JNJ0966 are dose-dependent, with plasma and brain concentrations for the 10-mg/kg dose of 77.5±31.1 ng/mL (215 nM) and 481.6±162.5 ng/g (~1336 nM), respectively, whereas the 30-mg/kg dose achieves 293.6±118.4 ng/mL (815 nM) in plasma and 1394.0±649.1 ng/g (~3867 nM) in brain. JNJ0966 is preferentially partitioned in brain, with brain/plasma ratios of 6.2 for the 10 mg/kg dose and 4.7 for the 30 mg/kg dose [1]. |
分子量 | 360.45 |
分子式 | C16H16N4O2S2 |
CAS No. | 315705-75-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 150 mg/mL(416.15 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.7743 mL | 13.8715 mL | 27.7431 mL | 69.3577 mL |
5 mM | 0.5549 mL | 2.7743 mL | 5.5486 mL | 13.8715 mL | |
10 mM | 0.2774 mL | 1.3872 mL | 2.7743 mL | 6.9358 mL | |
20 mM | 0.1387 mL | 0.6936 mL | 1.3872 mL | 3.4679 mL | |
50 mM | 0.0555 mL | 0.2774 mL | 0.5549 mL | 1.3872 mL | |
100 mM | 0.0277 mL | 0.1387 mL | 0.2774 mL | 0.6936 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
JNJ0966 315705-75-0 Proteases/Proteasome MMP Inhibitor Matrix metalloproteinases JNJ 0966 JNJ-0966 inhibit inhibitor